{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.95G>T (p.A30P)",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "T",
            "position": "95"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "c.95G>T (p.A30P)"
        },
        {
          "HGVS": "NM_001126112.3:c.137A>A (p.E46K)",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "c.137A>A (p.E46K)"
        },
        {
          "HGVS": "NM_001126112.3:c.158G>T (p.A53T)",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "c.158G>T (p.A53T)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0004976"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro proteasome assay and amyloid aggregation study",
      "Material used": {
        "Material Source": "Cell-derived or recombinant α-synuclein proteins",
        "Material Name": "Wildtype and mutant α-synuclein (A30P, E46K, A53T)",
        "Description": "The experiments were conducted using wildtype and mutant α-synuclein proteins subjected to proteolytic cleavage by the 20S proteasome and tested for their ability to form amyloid fibrils."
      },
      "Readout type": "Qualitative (observation of aggregation and fragmentation)",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.95G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Missense mutation leading to altered protein behavior",
          "Result Description": "The A30P mutant showed increased susceptibility to proteasomal cleavage and altered aggregation properties compared to wildtype α-synuclein."
        },
        {
          "Variant": "NM_001126112.3:c.137A>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Missense mutation leading to altered protein behavior",
          "Result Description": "The E46K mutant exhibited reduced proteasomal degradation rates and enhanced amyloid fibril formation."
        },
        {
          "Variant": "NM_001126112.3:c.158G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Missense mutation leading to altered protein behavior",
          "Result Description": "The A53T mutant displayed increased proteasomal cleavage and enhanced aggregation propensity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Number of biological replicates not specified in the literature context."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Details on technical replicates not provided."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wildtype α-synuclein was used as the positive control for comparison."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "No explicit negative control mentioned in the context."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal proteasomal cleavage and aggregation behavior as observed in wildtype α-synuclein.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Altered proteasomal cleavage rates or enhanced amyloid fibril formation compared to wildtype.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Explanation": "In vitro assays evaluating proteasomal degradation and amyloid aggregation are commonly used in neurodegenerative disease research, including studies on Parkinson's disease."
      }
    }
  ]
}